CN1198950A - Preparation of medicine for colitis - Google Patents
Preparation of medicine for colitis Download PDFInfo
- Publication number
- CN1198950A CN1198950A CN 98101426 CN98101426A CN1198950A CN 1198950 A CN1198950 A CN 1198950A CN 98101426 CN98101426 CN 98101426 CN 98101426 A CN98101426 A CN 98101426A CN 1198950 A CN1198950 A CN 1198950A
- Authority
- CN
- China
- Prior art keywords
- colitis
- preparation
- medicine
- glucose
- new drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A medicine for treating acute, chronic and ulcerative colitis is prepared through dissolving humic acid, thymic peptide and glucose in water or glucose solution, and features high curative effect, low cost and simple preparing process.
Description
The present invention is a kind of preparation of colitis new drug, belongs to field of pharmaceutical technology.
The medicine general cost of treatment colitis is all high at present, and treatment cycle is longer, and curative effect is undesirable.
The objective of the invention is: development provides a kind of new drug for the treatment of colitis, and this medicine manufacturing process is simple, and cost is low, and good effect is easy to use.
The preparation of a kind of colitis new drug of the present invention is to be dissolved in the solvent by compositions such as humic acids, thymosin and glucoses to form.
Concrete manufacture method is as follows: put into humic acids 10 to 30 grams, thymosin 0.01 to 0.1 gram, glucose 10 to 30 grams in solvent is 250 milliliters water, make three kinds of compositions soluble in water through rocking or stirring, the solvent that uses is that distilled water or cold water or other are through the disinfectant pure water or use 5% glucose solution, if, then can accelerate dissolution velocity with warm water (about 40 ℃) dissolving.
The preparation of a kind of colitis new drug of the present invention, this medicine is a medicine for external use, has no side effect.Severe case every day sooner or later each coloclysis once, each 50 milliliters, hypopathia patient is every night with 50 milliliters of coloclysis once.
The preparation of a kind of colitis new drug of the present invention, this medicine warp and unit clinical trials such as the Chinese Academy of Sciences, space flight hospital prove good effect, and cost is low and easy to use, to acute/chronic colitis and patients of ulcerative colitis, can both obtain the effective treatment, and therapeutic effect is obvious.
Now as follows for embodiment:
Embodiment one: adopt humic acids (Powdered) 20 grams, thymosin (Powdered) 0.05 gram and glucose (Powdered) 20 grams, after three kinds of compositions are mixed, form with 250 milliliters of dissolvings of distilled water.
Embodiment two: adopt humic acids 12 grams, thymosin 0.01 gram and glucose 10 grams, form with 250 milliliters of dissolvings of distilled water.
Claims (3)
1. the preparation of a colitis new drug is characterized in that: this medicine is dissolved in the solvent by humic acids, thymosin and glucose and forms.
2. the preparation of a kind of colitis new drug according to claim 1 is characterized in that: the preparation of this medicine is to put into humic acids 10 to 30 grams, thymosin 0.01 to 0.1 gram and glucose 10 to 30 gram dissolvings to form in solvent is 250 milliliters water.
3. the preparation of a kind of colitis new drug according to claim 1 and 2 is characterized in that: wherein solvent is to adopt 5% glucose solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 98101426 CN1198950A (en) | 1998-04-24 | 1998-04-24 | Preparation of medicine for colitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 98101426 CN1198950A (en) | 1998-04-24 | 1998-04-24 | Preparation of medicine for colitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1198950A true CN1198950A (en) | 1998-11-18 |
Family
ID=5216688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 98101426 Pending CN1198950A (en) | 1998-04-24 | 1998-04-24 | Preparation of medicine for colitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1198950A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008050363A3 (en) * | 2006-10-27 | 2008-06-26 | Sigma Tau Ind Farmaceuti | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
-
1998
- 1998-04-24 CN CN 98101426 patent/CN1198950A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008050363A3 (en) * | 2006-10-27 | 2008-06-26 | Sigma Tau Ind Farmaceuti | Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7309502B2 (en) | Pharmaceutical compositions for treating and saving and the method for the preparation thereof | |
| CN1915222B (en) | Composition of liposome, and preparation method | |
| CN1141929C (en) | Medicament and method of treating an organism with medicaments | |
| CN101947234A (en) | Preparation method for preparation containing glucosamine and application thereof | |
| CN1198950A (en) | Preparation of medicine for colitis | |
| CN100502878C (en) | Fusidate sodium composition and preparation of its freeze-drying formulation | |
| CN1067577C (en) | Preparation of isotomic Shengmei injecta | |
| CN1284585C (en) | Medicine for treating acute and chronic pharyogolaryngitis, recurring oral cavity sore and its preparation method | |
| CN104887693A (en) | Pharmaceutical composition for treating osteoporosis, liposome preparation of pharmaceutical composition, and preparation method thereof | |
| CN1961888B (en) | Lyophilized powder injection of baikal skullcap root extract and preparation method thereof | |
| CN1663563A (en) | Compound troxerutin and piracetam formulation and application thereof | |
| CN101422438A (en) | Composite diisopropyiarmini dichloroacetas freeze-dry preparation without adjuvant and preparation technique thereof | |
| CN1058154C (en) | Medicine for treatment of pile | |
| CN101129329A (en) | Injection containing huperzine for sulci venosi and method of preparing the same | |
| CN102008461A (en) | Ibuprofen drug composite for injection | |
| CN1101276A (en) | External-use medicine composition for vaginitis | |
| CN114452248B (en) | Bovine pulmonary heparin sodium hydrogel preparation, hydrogel patch and application thereof | |
| CN1839882A (en) | Medicament composition for treating tinea pedis and tinea corporis | |
| CN1542009A (en) | Preparation method and use of dipyridanmole derivative | |
| CN1359678A (en) | Process for preparing houttuyninum sodium injection | |
| CN1046411C (en) | Injection for curing psoriasic | |
| CN1712009A (en) | Externally-applied medicinal liquid for treating acne, rosacea and folliculitis | |
| CN114452248A (en) | Bovine lung heparin sodium hydrogel preparation, hydrogel patch and application thereof | |
| CN1295862A (en) | Medicine for treating osteoporosis and hyperosteogeny and preparation process thereof | |
| CN1273134C (en) | Soft capsule of fibrauretine and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |